Sonkar Satyendra K, Gupta Akash, Sonkar Gyanendra K, Usman Kauser, Bhosale Vivek, Kumar Satish, Sharma Sharad
Medicine, King George's Medical University, Lucknow, IND.
Biochemistry, King George's Medical University, Lucknow, IND.
Cureus. 2023 Mar 11;15(3):e36011. doi: 10.7759/cureus.36011. eCollection 2023 Mar.
Background and objectives Microalbuminuria is an early sign of diabetic nephropathy (DN). However, pathological abnormalities occur before the onset of microalbuminuria. Renal impairment progresses in about 50% of cases in type 2 diabetes mellitus (T2DM) without significant albuminuria. Diabetes mellitus (DM) is linked with obesity, metabolic syndrome, and lifestyle changes, where adipokines play an important role. Zinc alpha 2 glycoprotein (ZAGP) is an adipokine, and in this study, it was assessed as a potential biomarker for early DN as well as its progression. Materials and methods This study was a cross-sectional case-control study conducted at a tertiary hospital in northern India. T2DM patients aged 18-65 years old were included in the study and were divided into four groups based on their albuminuria level. This study included 160 participants, with 40 participants in each group. Group I included healthy volunteers, while Groups II, III, and IV were normoalbuminuric, microalbuminuric, and macroalbuminuric diabetic patients, respectively. The groups were evaluated for demographic variables, biochemical parameters, urine albumin-creatinine ratio (UACR), and serum ZAGP. Data between the groups were compared statistically. Results This study included 160 participants, with 40 participants in each group. There was a significant difference between the groups based on the serum ZAGP (p<0.001). Serum ZAGP was significantly negatively correlated with serum creatinine, glycosylated hemoglobin (HbA1c), serum cholesterol, serum triglyceride, low-density lipoprotein (LDL) cholesterol, and UACR. ZAGP was positively correlated with the estimated glomerular filtration rate (eGFR). Conclusion The present study showed that ZAGP was an early biomarker of diabetic nephropathy, and its value decreased as DN progressed. It also suggested that ZAGP, an adipokine, has an anti-inflammatory mechanism of action and its depletion worsens the disease.
背景与目的 微量白蛋白尿是糖尿病肾病(DN)的早期迹象。然而,病理异常在微量白蛋白尿出现之前就已发生。在2型糖尿病(T2DM)患者中,约50%无明显蛋白尿的病例会出现肾功能损害进展。糖尿病(DM)与肥胖、代谢综合征及生活方式改变有关,其中脂肪因子起着重要作用。锌α2糖蛋白(ZAGP)是一种脂肪因子,在本研究中,它被评估为早期DN及其进展的潜在生物标志物。材料与方法 本研究是在印度北部一家三级医院进行的横断面病例对照研究。纳入年龄在18 - 65岁的T2DM患者,并根据其白蛋白尿水平分为四组。本研究共纳入160名参与者,每组40人。第一组包括健康志愿者,而第二、三、四组分别为正常白蛋白尿、微量白蛋白尿和大量白蛋白尿的糖尿病患者。对各组进行人口统计学变量、生化参数、尿白蛋白 - 肌酐比值(UACR)和血清ZAGP评估。对组间数据进行统计学比较。结果 本研究共纳入160名参与者,每组40人。基于血清ZAGP,各组间存在显著差异(p<0.001)。血清ZAGP与血清肌酐、糖化血红蛋白(HbA1c)、血清胆固醇、血清甘油三酯、低密度脂蛋白(LDL)胆固醇和UACR显著负相关。ZAGP与估计肾小球滤过率(eGFR)正相关。结论 本研究表明,ZAGP是糖尿病肾病的早期生物标志物,其值随DN进展而降低。研究还提示,脂肪因子ZAGP具有抗炎作用机制,其减少会使病情恶化。